238 related articles for article (PubMed ID: 15731107)
1. A structural basis for 14-3-3sigma functional specificity.
Wilker EW; Grant RA; Artim SC; Yaffe MB
J Biol Chem; 2005 May; 280(19):18891-8. PubMed ID: 15731107
[TBL] [Abstract][Full Text] [Related]
2. The crystal structure of the non-liganded 14-3-3sigma protein: insights into determinants of isoform specific ligand binding and dimerization.
Benzinger A; Popowicz GM; Joy JK; Majumdar S; Holak TA; Hermeking H
Cell Res; 2005 Apr; 15(4):219-27. PubMed ID: 15857576
[TBL] [Abstract][Full Text] [Related]
3. Protein 14-3-3sigma interacts with and favors cytoplasmic subcellular localization of the glucocorticoid receptor, acting as a negative regulator of the glucocorticoid signaling pathway.
Kino T; Souvatzoglou E; De Martino MU; Tsopanomihalu M; Wan Y; Chrousos GP
J Biol Chem; 2003 Jul; 278(28):25651-6. PubMed ID: 12730237
[TBL] [Abstract][Full Text] [Related]
4. Binding of 14-3-3beta but not 14-3-3sigma controls the cytoplasmic localization of CDC25B: binding site preferences of 14-3-3 subtypes and the subcellular localization of CDC25B.
Uchida S; Kuma A; Ohtsubo M; Shimura M; Hirata M; Nakagama H; Matsunaga T; Ishizaka Y; Yamashita K
J Cell Sci; 2004 Jun; 117(Pt 14):3011-20. PubMed ID: 15173315
[TBL] [Abstract][Full Text] [Related]
5. 14-3-3 sigma isoform interacts with the cytoplasmic domain of the transmembrane BP180 in keratinocytes.
Li Y; Lin X; Kilani RT; Jones JC; Ghahary A
J Cell Physiol; 2007 Sep; 212(3):675-81. PubMed ID: 17443672
[TBL] [Abstract][Full Text] [Related]
6. Characterization of 14-3-3sigma dimerization determinants: requirement of homodimerization for inhibition of cell proliferation.
Verdoodt B; Benzinger A; Popowicz GM; Holak TA; Hermeking H
Cell Cycle; 2006 Dec; 5(24):2920-6. PubMed ID: 17172876
[TBL] [Abstract][Full Text] [Related]
7. Critical residue that promotes protein dimerization: a story of partially exposed Phe25 in 14-3-3σ.
Liu JY; Li Z; Li H; Zhang JT
J Chem Inf Model; 2011 Oct; 51(10):2612-25. PubMed ID: 21870863
[TBL] [Abstract][Full Text] [Related]
8. 14-3-3sigma negatively regulates the cell cycle, and its down-regulation is associated with poor outcome in intrahepatic cholangiocarcinoma.
Kuroda Y; Aishima S; Taketomi A; Nishihara Y; Iguchi T; Taguchi K; Maehara Y; Tsuneyoshi M
Hum Pathol; 2007 Jul; 38(7):1014-1022. PubMed ID: 17391729
[TBL] [Abstract][Full Text] [Related]
9. 14-3-3sigma controls mitotic translation to facilitate cytokinesis.
Wilker EW; van Vugt MA; Artim SA; Huang PH; Petersen CP; Reinhardt HC; Feng Y; Sharp PA; Sonenberg N; White FM; Yaffe MB
Nature; 2007 Mar; 446(7133):329-32. PubMed ID: 17361185
[TBL] [Abstract][Full Text] [Related]
10. 14-3-3sigma mediation of cell cycle progression is p53-independent in response to insulin-like growth factor-I receptor activation.
Zhang Y; Karas M; Zhao H; Yakar S; LeRoith D
J Biol Chem; 2004 Aug; 279(33):34353-60. PubMed ID: 15187095
[TBL] [Abstract][Full Text] [Related]
11. Extracellular 14-3-3sigma protein: a potential mediator of epithelial-mesenchymal interactions.
Hermeking H
J Invest Dermatol; 2005 Jan; 124(1):ix-x. PubMed ID: 15654940
[No Abstract] [Full Text] [Related]
12. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
Pulukuri SM; Rao JS
Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
[TBL] [Abstract][Full Text] [Related]
13. 14-3-3sigma, a p53 regulator, suppresses tumor growth of nasopharyngeal carcinoma.
Yang H; Zhao R; Lee MH
Mol Cancer Ther; 2006 Feb; 5(2):253-60. PubMed ID: 16505098
[TBL] [Abstract][Full Text] [Related]
14. 14-3-3sigma and p21 synergize to determine DNA damage response following Chk2 inhibition.
Meng S; Arbit T; Veeriah S; Mellinghoff IK; Fang F; Vivanco I; Rohle D; Chan TA
Cell Cycle; 2009 Jul; 8(14):2238-46. PubMed ID: 19502805
[TBL] [Abstract][Full Text] [Related]
15. Interaction of 14-3-3σ with KCMF1 suppresses the proliferation and colony formation of human colon cancer stem cells.
Zou J; Mi L; Yu XF; Dong J
World J Gastroenterol; 2013 Jun; 19(24):3770-80. PubMed ID: 23840115
[TBL] [Abstract][Full Text] [Related]
16. Sensitizing hormone-refractory prostate cancer cells to drug treatment by targeting 14-3-3sigma.
Han B; Xie H; Chen Q; Zhang JT
Mol Cancer Ther; 2006 Apr; 5(4):903-12. PubMed ID: 16648560
[TBL] [Abstract][Full Text] [Related]
17. Cooperative effect of p21Cip1/WAF-1 and 14-3-3sigma on cell cycle arrest and apoptosis induction by p14ARF.
Hemmati PG; Normand G; Gillissen B; Wendt J; Dörken B; Daniel PT
Oncogene; 2008 Dec; 27(53):6707-19. PubMed ID: 18806827
[TBL] [Abstract][Full Text] [Related]
18. 14-3-3sigma is a cruciform DNA binding protein and associates in vivo with origins of DNA replication.
Alvarez D; Novac O; Callejo M; Ruiz MT; Price GB; Zannis-Hadjopoulos M
J Cell Biochem; 2002; 87(2):194-207. PubMed ID: 12244572
[TBL] [Abstract][Full Text] [Related]
19. Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions.
Henrique R; Jerónimo C; Hoque MO; Carvalho AL; Oliveira J; Teixeira MR; Lopes C; Sidransky D
DNA Cell Biol; 2005 Apr; 24(4):264-9. PubMed ID: 15812243
[TBL] [Abstract][Full Text] [Related]
20. Negative cell cycle regulator 14-3-3sigma stabilizes p27 Kip1 by inhibiting the activity of PKB/Akt.
Yang H; Zhang Y; Zhao R; Wen YY; Fournier K; Wu HB; Yang HY; Diaz J; Laronga C; Lee MH
Oncogene; 2006 Aug; 25(33):4585-94. PubMed ID: 16532026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
